| 3502 | A | 074014 | 003 | KETOPROFEN | CAPSULE;ORAL | CAPSULE | ORAL | KETOPROFEN | HERITAGE PHARMS INC | 75MG | AB | ["AB"] | 1993-01-29 | Jan 29, 1993 | No | No | No | RX | HERITAGE PHARMACEUTICALS INC | b4d54a2274a977a46759d94c071e429b8f3c46ad7db689c286ca4d1439d28267 |
| 3503 | A | 074035 | 002 | KETOPROFEN | CAPSULE;ORAL | CAPSULE | ORAL | KETOPROFEN | MYLAN | 50MG | | [] | 1996-12-31 | Dec 31, 1996 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | fa9747b19ac6bdd9a65e9bb4f757f9d51f2e0a5e2a47d1d0502b9276cd191fe6 |
| 3504 | A | 074035 | 003 | KETOPROFEN | CAPSULE;ORAL | CAPSULE | ORAL | KETOPROFEN | MYLAN | 75MG | | [] | 1996-12-31 | Dec 31, 1996 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | c6b3522ff2d1a38893fed23ccdca336ce033be512d820c0b8e8b5a7c610565a7 |
| 3505 | A | 074024 | 001 | KETOPROFEN | CAPSULE;ORAL | CAPSULE | ORAL | KETOPROFEN | RISING | 50MG | | [] | 1995-12-29 | Dec 29, 1995 | No | No | No | DISCN | RISING PHARMA HOLDINGS INC | 4abb50a14ff0bfc11a9751e9d5cc076f3a7031a091524b8986137bf5a508ea0e |
| 3506 | A | 074024 | 002 | KETOPROFEN | CAPSULE;ORAL | CAPSULE | ORAL | KETOPROFEN | RISING | 75MG | | [] | 1995-12-29 | Dec 29, 1995 | No | No | No | DISCN | RISING PHARMA HOLDINGS INC | dcfd563e5edcb903cb99f8a98338d209a1c53f4bc710bbe59011debd3a1fc6ae |
| 3507 | A | 073515 | 001 | KETOPROFEN | CAPSULE;ORAL | CAPSULE | ORAL | KETOPROFEN | TEVA | 25MG | | [] | 1992-12-22 | Dec 22, 1992 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | e0831a11f57aa05f298e013ce2d6c3db797b24e05846a662b53193ed80c81630 |
| 3508 | A | 073516 | 001 | KETOPROFEN | CAPSULE;ORAL | CAPSULE | ORAL | KETOPROFEN | TEVA | 50MG | AB | ["AB"] | 1992-12-22 | Dec 22, 1992 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | 4aa0d39c1b1bbeb3f9e107479e039ca4b9a276828deb649d76a6dcf8a621dcd1 |
| 3509 | A | 073517 | 001 | KETOPROFEN | CAPSULE;ORAL | CAPSULE | ORAL | KETOPROFEN | TEVA | 75MG | AB | ["AB"] | 1992-12-22 | Dec 22, 1992 | No | No | Yes | RX | TEVA PHARMACEUTICALS USA INC | 7e66879a90783312402cd7b24818ecc61905b38a82c0f46bdab5971aad83ac2c |
| 3510 | N | 213756 | 001 | SELUMETINIB SULFATE | CAPSULE;ORAL | CAPSULE | ORAL | KOSELUGO | ASTRAZENECA | EQ 10MG BASE | | [] | 2020-04-10 | Apr 10, 2020 | No | Yes | No | RX | ASTRAZENECA PHARMACEUTICALS LP | 392a389d28d7dcd431799fa5bf0d5e7fc5d0c822a57384240258ec0466d2f0ac |
| 3511 | N | 213756 | 002 | SELUMETINIB SULFATE | CAPSULE;ORAL | CAPSULE | ORAL | KOSELUGO | ASTRAZENECA | EQ 25MG BASE | | [] | 2020-04-10 | Apr 10, 2020 | No | Yes | Yes | RX | ASTRAZENECA PHARMACEUTICALS LP | 6440e21a2773327a47a5fb67c86e4d531c9215a07243837a4de4d6b4ab6e9a18 |
| 3512 | N | 019500 | 002 | CLOFAZIMINE | CAPSULE;ORAL | CAPSULE | ORAL | LAMPRENE | NOVARTIS | 50MG | | [] | 1986-12-15 | Dec 15, 1986 | No | Yes | No | DISCN | NOVARTIS PHARMACEUTICALS CORP | 7d378b12f87033d36e40a048dd5aee01320e5f60b501fe8ca8e3819d9ac1d3b9 |
| 3513 | N | 019500 | 001 | CLOFAZIMINE | CAPSULE;ORAL | CAPSULE | ORAL | LAMPRENE | NOVARTIS | 100MG | | [] | 1986-12-15 | Dec 15, 1986 | No | No | No | DISCN | NOVARTIS PHARMACEUTICALS CORP | 2ae4731194da5b49ce3ae7a148d961e6f17326dbb9cc63dc25da8d38615dc261 |
| 3514 | A | 086996 | 002 | ASPIRIN; BUTALBITAL; CAFFEINE | CAPSULE;ORAL | CAPSULE | ORAL | LANORINAL | LANNETT | 325MG;50MG;40MG | AA | ["AA"] | 1985-10-11 | Oct 11, 1985 | No | No | No | RX | LANNETT CO INC | c9d08de789e8ba44b4469d4ab86566f3b2a7058703b6bf1531b1eb693a384fbf |
| 3515 | N | 018118 | 002 | DIGOXIN | CAPSULE;ORAL | CAPSULE | ORAL | LANOXICAPS | GLAXOSMITHKLINE LLC | 0.05MG | | [] | 1982-07-26 | Jul 26, 1982 | No | No | No | DISCN | GLAXOSMITHKLINE LLC | b93d80ca451cbbeab44825fb6d2cecb07a3378d51ecef9f365ded6fff75b4873 |
| 3516 | N | 018118 | 003 | DIGOXIN | CAPSULE;ORAL | CAPSULE | ORAL | LANOXICAPS | GLAXOSMITHKLINE LLC | 0.1MG | | [] | 1982-07-26 | Jul 26, 1982 | No | No | No | DISCN | GLAXOSMITHKLINE LLC | 03cdb2b0962d16b02016be98e1248d25806e144c8e4a5a2b1a9600a0b8315e88 |
| 3517 | N | 018118 | 004 | DIGOXIN | CAPSULE;ORAL | CAPSULE | ORAL | LANOXICAPS | GLAXOSMITHKLINE LLC | 0.15MG | | [] | 1984-09-24 | Sep 24, 1984 | No | No | No | DISCN | GLAXOSMITHKLINE LLC | 3c0f46638b80eed2531056fcf858134fea5e840ee4b883f9c8c35f527941950d |
| 3518 | N | 018118 | 001 | DIGOXIN | CAPSULE;ORAL | CAPSULE | ORAL | LANOXICAPS | GLAXOSMITHKLINE LLC | 0.2MG | | [] | 1982-07-26 | Jul 26, 1982 | No | No | No | DISCN | GLAXOSMITHKLINE LLC | ebd39697c0a8d72ba67d2be522fc8d9f25d25e3487a84c30c33a2554000f0187 |
| 3519 | N | 016912 | 002 | LEVODOPA | CAPSULE;ORAL | CAPSULE | ORAL | LARODOPA | ROCHE | 100MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | HOFFMANN LA ROCHE INC | 48fdad2aa8969c6d2f8770ce23c1f2f725db9af9c6b968564b0bbbe3bc42046a |
| 3520 | N | 016912 | 001 | LEVODOPA | CAPSULE;ORAL | CAPSULE | ORAL | LARODOPA | ROCHE | 250MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | HOFFMANN LA ROCHE INC | 2f4a02157abba47b3cc0ea393222bee828dc6b0d47d44646d6939aee9a69fc04 |
| 3521 | N | 016912 | 006 | LEVODOPA | CAPSULE;ORAL | CAPSULE | ORAL | LARODOPA | ROCHE | 500MG | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | HOFFMANN LA ROCHE INC | d3b6a802b28cdb0f47fda32f0cdc23d1cf003b84875e2e1d924a0741048bc29d |
| 3522 | N | 206947 | 001 | LENVATINIB MESYLATE | CAPSULE;ORAL | CAPSULE | ORAL | LENVIMA | EISAI INC | EQ 4MG BASE | | [] | 2015-02-13 | Feb 13, 2015 | No | Yes | No | RX | EISAI INC | 5751a13918af89e19af02d7885502e1257628e6b79d3fa86a6934509faf2e18d |
| 3523 | N | 206947 | 002 | LENVATINIB MESYLATE | CAPSULE;ORAL | CAPSULE | ORAL | LENVIMA | EISAI INC | EQ 10MG BASE | | [] | 2015-02-13 | Feb 13, 2015 | No | Yes | Yes | RX | EISAI INC | a119a3552aae8c7928c8c33524a273345aceb1e41db0b52fb67990e4dae683a0 |
| 3524 | N | 020261 | 001 | FLUVASTATIN SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | LESCOL | NOVARTIS | EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1993-12-31 | Dec 31, 1993 | No | Yes | No | DISCN | NOVARTIS PHARMACEUTICALS CORP | f65b8eca31ec014f5806d81206582a04f6bf0a6be8a560db30ddabc530e2e157 |
| 3525 | N | 020261 | 002 | FLUVASTATIN SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | LESCOL | NOVARTIS | EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1993-12-31 | Dec 31, 1993 | No | Yes | No | DISCN | NOVARTIS PHARMACEUTICALS CORP | c2f4047623999c844b7f1aaf5d57e486e4f8fa5d64a53ed5b3a3ef01ce92f6b3 |
| 3526 | A | 211369 | 001 | LEVOTHYROXINE SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | LEVOTHYROXINE SODIUM | TEVA PHARMS USA INC | 0.075MG | AB | ["AB"] | 2020-10-28 | Oct 28, 2020 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | 85c1f4f3523574983590168321e3de34ea817ef4bd2c747b7a36c93b1a0c7ab7 |
| 3527 | A | 213256 | 001 | LEVOTHYROXINE SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | LEVOTHYROXINE SODIUM | TEVA PHARMS USA INC | 0.088MG | AB | ["AB"] | 2021-01-06 | Jan 6, 2021 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | 229df4d9b47b0fb553198f838b48d723a4213bad6b46ca5eb7a06e3848599e03 |
| 3528 | A | 213256 | 002 | LEVOTHYROXINE SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | LEVOTHYROXINE SODIUM | TEVA PHARMS USA INC | 0.1MG | AB | ["AB"] | 2021-01-06 | Jan 6, 2021 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | a0abfcc9719f55f23b8e2f7bba3def29a1489fb353dd828271283d7a1510f05b |
| 3529 | A | 213256 | 003 | LEVOTHYROXINE SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | LEVOTHYROXINE SODIUM | TEVA PHARMS USA INC | 0.125MG | AB | ["AB"] | 2021-01-06 | Jan 6, 2021 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | 98c92b23b939cd0a079d396321a846a0bd104825a8b6c702a7f4d80d72b73c5d |
| 3530 | A | 211369 | 002 | LEVOTHYROXINE SODIUM | CAPSULE;ORAL | CAPSULE | ORAL | LEVOTHYROXINE SODIUM | TEVA PHARMS USA INC | 0.15MG | AB | ["AB"] | 2020-10-28 | Oct 28, 2020 | No | No | No | RX | TEVA PHARMACEUTICALS USA INC | 0f8500fdb845e1ab563f702e0e335409987203e72d9e164e3044f7668accaa02 |
| 3531 | N | 012750 | 001 | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE | CAPSULE;ORAL | CAPSULE | ORAL | LIBRAX | BAUSCH | 5MG;2.5MG | AB | ["AB"] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | BAUSCH HEALTH US LLC | 004ebef5e5153c797017d4ed051aa46b3f35c0dc227de5b07c663473230d47ff |
| 3532 | A | 085461 | 001 | CHLORDIAZEPOXIDE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | LIBRIUM | VALEANT PHARM INTL | 5MG | AB | ["AB"] | | Approved Prior to Jan 1, 1982 | Yes | No | No | RX | VALEANT PHARMACEUTICALS INTERNATIONAL | 63187492cb09ee30e0dd2110df0823cb223ea4c2822c62b1b75efb9c937a85bd |
| 3533 | N | 012249 | 002 | CHLORDIAZEPOXIDE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | LIBRIUM | VALEANT PHARM INTL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | VALEANT PHARMACEUTICALS INTERNATIONAL | 954e9b7b4c495a9233ee3189560c046a1609cb6a2d54236e9f9fe83d8b5cb4ff |
| 3534 | A | 085472 | 001 | CHLORDIAZEPOXIDE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | LIBRIUM | VALEANT PHARM INTL | 10MG | AB | ["AB"] | | Approved Prior to Jan 1, 1982 | Yes | No | No | RX | VALEANT PHARMACEUTICALS INTERNATIONAL | a97aecde2ce46903079da79e99f0ff92d7777df0832788227b702d6886266e18 |
| 3535 | N | 012249 | 001 | CHLORDIAZEPOXIDE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | LIBRIUM | VALEANT PHARM INTL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | VALEANT PHARMACEUTICALS INTERNATIONAL | e8bad935e1458de03de432e3ca320ab2f3f92fb0aa386157bf41778621aa7fb0 |
| 3536 | A | 085475 | 001 | CHLORDIAZEPOXIDE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | LIBRIUM | VALEANT PHARM INTL | 25MG | AB | ["AB"] | | Approved Prior to Jan 1, 1982 | Yes | No | Yes | RX | VALEANT PHARMACEUTICALS INTERNATIONAL | 3e96d51773aff1d00db993a20fd2e2dddca220ae7be712b16f97039984cfde81 |
| 3537 | N | 012249 | 003 | CHLORDIAZEPOXIDE HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | LIBRIUM | VALEANT PHARM INTL | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | VALEANT PHARMACEUTICALS INTERNATIONAL | 9fb44c76c093cae4509c9fdc9af890c75db14d598a32e44a8058128a8a92c1a2 |
| 3538 | A | 209564 | 001 | LINACLOTIDE | CAPSULE;ORAL | CAPSULE | ORAL | LINACLOTIDE | MYLAN | 145MCG | | [] | 2021-02-09 | Feb 9, 2021 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 5a316469564a859a84d27deeb961f8b1e1adcb0a1aac61ccb063608f050030dd |
| 3539 | A | 209564 | 002 | LINACLOTIDE | CAPSULE;ORAL | CAPSULE | ORAL | LINACLOTIDE | MYLAN | 290MCG | | [] | 2021-02-09 | Feb 9, 2021 | No | No | No | DISCN | MYLAN PHARMACEUTICALS INC | 44bed89908ebe994d36f6ba9f6788a369388d76909d12ff025bd0cdb39a55d17 |
| 3540 | N | 050316 | 001 | LINCOMYCIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | LINCOCIN | PHARMACIA AND UPJOHN | EQ 250MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PHARMACIA AND UPJOHN CO | 6fe8bdc3813b7b64054784201f77a130827cc4a1abeb866467ba50c60e3585c2 |
| 3541 | N | 050316 | 002 | LINCOMYCIN HYDROCHLORIDE | CAPSULE;ORAL | CAPSULE | ORAL | LINCOCIN | PHARMACIA AND UPJOHN | EQ 500MG BASE | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | PHARMACIA AND UPJOHN CO | 6012d89fc3d24ec4c85f8cd7021f446d0d46cdcc9e78a36004e0c67a3490349d |
| 3542 | N | 202811 | 003 | LINACLOTIDE | CAPSULE;ORAL | CAPSULE | ORAL | LINZESS | ALLERGAN | 72MCG | | [] | 2017-01-25 | Jan 25, 2017 | No | Yes | Yes | RX | ALLERGAN SALES LLC | 39226ac9f3bd4b5d2733948c8776c4bbe5d9d556a157ded7fb475e0f5befb82f |
| 3543 | N | 202811 | 001 | LINACLOTIDE | CAPSULE;ORAL | CAPSULE | ORAL | LINZESS | ALLERGAN | 145MCG | | [] | 2012-08-30 | Aug 30, 2012 | No | Yes | Yes | RX | ALLERGAN SALES LLC | eb9f555906a60b8a0bb317ee9572523ce2214c56118da6eb82eb7466e83b6e46 |
| 3544 | N | 202811 | 002 | LINACLOTIDE | CAPSULE;ORAL | CAPSULE | ORAL | LINZESS | ALLERGAN | 290MCG | | [] | 2012-08-30 | Aug 30, 2012 | No | Yes | No | RX | ALLERGAN SALES LLC | c30688c60ace5d747833c5af2c30a7b9925ee612568ad401a85abe28b29306a6 |
| 3545 | N | 019304 | 001 | FENOFIBRATE | CAPSULE;ORAL | CAPSULE | ORAL | LIPIDIL | ABBVIE | 100MG | | [] | 1993-12-31 | Dec 31, 1993 | No | No | No | DISCN | ABBVIE INC | 0437979dbbaa4ef4ed5d42f9eb15f3032e1a6475836db7f42689233fdca5825c |
| 3546 | N | 021612 | 001 | FENOFIBRATE | CAPSULE;ORAL | CAPSULE | ORAL | LIPOFEN | CIPHER PHARMS INC | 50MG | | [] | 2006-01-11 | Jan 11, 2006 | No | Yes | No | RX | CIPHER PHARMACEUTICALS INC | aa38ee47daa182c52ad8968422394dbe348113f04fa9dfefab87c875f4f6f5cc |
| 3547 | N | 021612 | 002 | FENOFIBRATE | CAPSULE;ORAL | CAPSULE | ORAL | LIPOFEN | CIPHER PHARMS INC | 100MG | | [] | 2006-01-11 | Jan 11, 2006 | No | No | No | DISCN | CIPHER PHARMACEUTICALS INC | c7dfecd8480d019d140fe490494a6378aba757d7d19f574ba569b37865ffaeaf |
| 3548 | N | 021612 | 003 | FENOFIBRATE | CAPSULE;ORAL | CAPSULE | ORAL | LIPOFEN | CIPHER PHARMS INC | 150MG | | [] | 2006-01-11 | Jan 11, 2006 | No | Yes | Yes | RX | CIPHER PHARMACEUTICALS INC | f63761baffee31997a81ac28099fee08e5cedae1a62935c729bf2a53e5b37296 |
| 3549 | A | 076823 | 001 | LITHIUM CARBONATE | CAPSULE;ORAL | CAPSULE | ORAL | LITHIUM CARBONATE | ABLE | 150MG | | [] | 2004-06-29 | Jun 29, 2004 | No | No | No | DISCN | ABLE LABORATORIES INC | 4a1c841c0c2db93c3b04c97d772199f067cc666227aea2e0af82811d3e0ae485 |
| 3550 | A | 076121 | 001 | LITHIUM CARBONATE | CAPSULE;ORAL | CAPSULE | ORAL | LITHIUM CARBONATE | ABLE | 300MG | | [] | 2001-09-27 | Sep 27, 2001 | No | No | No | DISCN | ABLE LABORATORIES INC | 3e361ab553bd1e3f0cde2e17e35728c716268f36f25ace67e9642fdbc2092b20 |
| 3551 | A | 076823 | 002 | LITHIUM CARBONATE | CAPSULE;ORAL | CAPSULE | ORAL | LITHIUM CARBONATE | ABLE | 300MG | | [] | 2004-06-29 | Jun 29, 2004 | No | No | No | DISCN | ABLE LABORATORIES INC | 0506964c9628d57018f46ad83e215f275a1446a26c88f475d1f8cb76e20f479e |